138 related articles for article (PubMed ID: 34934763)
41. Living Donor Liver Transplantation in a Cohort of Recipients With Left Ventricular Systolic Dysfunction.
Bhangui P; Bhangui P; Aneja M; Sharma N; Gupta N; Soin AS; Vohra V
J Clin Exp Hepatol; 2022; 12(4):1040-1047. PubMed ID: 35814511
[TBL] [Abstract][Full Text] [Related]
42. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
[TBL] [Abstract][Full Text] [Related]
43. Artificial intelligence for predicting survival following deceased donor liver transplantation: Retrospective multi-center study.
Yu YD; Lee KS; Man Kim J; Ryu JH; Lee JG; Lee KW; Kim BW; Kim DS;
Int J Surg; 2022 Sep; 105():106838. PubMed ID: 36028137
[TBL] [Abstract][Full Text] [Related]
44. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
Jiang ZS; Jiang JN
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709
[TBL] [Abstract][Full Text] [Related]
45. HEPATOCELLULAR CARCINOMA PATIENTS ARE ADVANTAGED IN THE CURRENT BRAZILIAN LIVER TRANSPLANT ALLOCATION SYSTEM. A COMPETING RISK ANALYSIS.
Rodríguez S; Fleck AM; Mucenic M; Marroni C; Brandão A
Arq Gastroenterol; 2020; 57(1):19-23. PubMed ID: 32294731
[TBL] [Abstract][Full Text] [Related]
46. The impact of pretransplant hepatic encephalopathy, model for end-stage liver disease (MELD) scale on long-term survival following deceased donor liver transplantation: a retrospective study.
Yoon JU; Yoo YM; Byeon GJ; Kim HJ; Choi EJ; Park S; Kim HY
Ann Palliat Med; 2021 May; 10(5):5171-5180. PubMed ID: 33894716
[TBL] [Abstract][Full Text] [Related]
47. Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume.
Ahmad J; Bryce CL; Cacciarelli T; Roberts MS
Ann Intern Med; 2007 May; 146(10):707-13. PubMed ID: 17502631
[TBL] [Abstract][Full Text] [Related]
48. Sex Disparity in Liver Transplant and Access to Living Donation.
Karnam RS; Chen S; Xu W; Chen C; Elangainesan P; Ghanekar A; McGilvray I; Reichman T; Sayed B; Selzner M; Sapisochin G; Galvin Z; Hirschfield G; Asrani SK; Selzner N; Cattral M; Lilly L; Bhat M
JAMA Surg; 2021 Nov; 156(11):1010-1017. PubMed ID: 34406347
[TBL] [Abstract][Full Text] [Related]
49. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
[TBL] [Abstract][Full Text] [Related]
50. [Application of different prognostic scores in liver transplantation decision-making for acute-on-chronic liver failure].
Xu MM; Wu Y; Li SS; Geng N; Lu W; Duan BW; Duan ZP; Li GM; Li J; Chen Y
Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):574-581. PubMed ID: 37400380
[No Abstract] [Full Text] [Related]
51. Model for End-stage Liver Disease.
Singal AK; Kamath PS
J Clin Exp Hepatol; 2013 Mar; 3(1):50-60. PubMed ID: 25755471
[TBL] [Abstract][Full Text] [Related]
52. [Usefulness of model for end-stage liver disease score for predicting mortality after intra-abdominal surgery in patients with liver cirrhosis in a single hospital].
Song CS; Yoon MY; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2011 Jun; 57(6):340-5. PubMed ID: 21694485
[TBL] [Abstract][Full Text] [Related]
53. Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine.
Lau T; Ahmad J
Hepat Med; 2013; 5():1-10. PubMed ID: 24696621
[TBL] [Abstract][Full Text] [Related]
54. Live donor liver transplantation in high MELD score recipients.
Selzner M; Kashfi A; Cattral MS; Selzner N; McGilvray ID; Greig PD; Levy GA; Renner EL; Grant DR
Ann Surg; 2010 Jan; 251(1):153-7. PubMed ID: 19858705
[TBL] [Abstract][Full Text] [Related]
55. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices.
Kim DH; Kim SH; Kim KS; Lee WJ; Kim NK; Noh SH; Kim CB
ANZ J Surg; 2014 Nov; 84(11):832-6. PubMed ID: 23647879
[TBL] [Abstract][Full Text] [Related]
56. Predictors of Outcome of Cirrhotic Patients Requiring Invasive Mechanical Ventilation: Experience From a Non-Transplant Tertiary Care Hospital in Pakistan.
Kamran M; Khalid AB; Siddiqui HAB; Aftab A; Azmat R
Cureus; 2022 Jan; 14(1):e21517. PubMed ID: 35223293
[TBL] [Abstract][Full Text] [Related]
57. [Comparative study of the MELD-Na and Child-Turcotte-Pugh scores as short-term prognostic indicators of acute-on-chronic hepatitis B liver failure].
Chen K; Cao X; Zheng Y; Xu M; Peng J
Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):801-5. PubMed ID: 25531374
[TBL] [Abstract][Full Text] [Related]
58. [Comparison of model for end-stage liver disease score with discriminant function and child-Turcotte-Pugh scores for predicting short-term mortality in Korean patients with alcoholic hepatitis].
Jeong JY; Sohn JH; Son BK; Paik CH; Kim SH; Han DS; Jeon YC; Lee MH; Lee DH; Kee CS
Korean J Gastroenterol; 2007 Feb; 49(2):93-9. PubMed ID: 17322788
[TBL] [Abstract][Full Text] [Related]
59. Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients.
Oberkofler CE; Dutkowski P; Stocker R; Schuepbach RA; Stover JF; Clavien PA; Béchir M
Crit Care; 2010; 14(3):R117. PubMed ID: 20550662
[TBL] [Abstract][Full Text] [Related]
60. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.
Poon KS; Chen TH; Jeng LB; Yang HR; Li PC; Lee CC; Yeh CC; Lai HC; Su WP; Peng CY; Chen YF; Ho YJ; Tsai PP
Transplant Proc; 2012 Mar; 44(2):316-9. PubMed ID: 22410005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
